Rationale: Sepsis, a life-threatening organ dysfunction caused by a dysregulated host response to infection, is a major public health concern with high mortality and morbidity. Although inflammatory responses triggered by infection are crucial for host defense against invading microbes, the excessive inflammation often causes tissue damage leading to organ dysfunction. Resolution of inflammation, an active immune process mediated by endogenous lipid mediators (LMs), is important to maintain host homeostasis.
The inflammasome is a molecular platform to promote maturation and secretion of proinflammatory cytokines, such as IL-1b and IL-18, in immune cells (1, 2) . Cytoplasmic receptors of the NLR family are critical components of the inflammasome and interact with the apoptosis-associated speck-like protein containing CARD (ASC), which recruits the precursor form of caspase-1 (1, 2) . The nucleotide-binding domain, leucine-rich repeat-containing receptor, pyrin domain-containing-3 (NLRP3) inflammasome is typically activated through a two-component pathway, involving toll-like receptor 4 ligand interaction (priming) followed by a second signal, such as ATP-dependent purinergic receptor (P2rx7) activation, which regulates K 1 efflux (1, 2). Unlike other inflammasomes, the NLRP3 inflammasome senses pathogenassociated molecular patterns and damageassociated molecular patterns (DAMPs), such as ATP and mitochondrial DNA (mtDNA) (1, 2) . On sensing pathogenassociated molecular patterns and/or DAMPs, NLRP3 recruits ASC and caspase-1, leading to caspase-1 activation, maturation and secretion of proinflammatory cytokines, such as IL-1b and IL-18, and initiating a lytic host cell death called pyroptosis (1) (2) (3) (4) .
Sepsis remains a major public health concern, and the number of sepsis cases per year is increasing because of the aging population, the increased longevity of people with chronic diseases, the spread of antibiotic-resistant organisms, and the broader use of immunosuppressive and chemotherapeutic agents (5, 6) . Although inflammatory responses observed in sepsis are important for host defense against invading microbes, the excessive inflammation often causes severe cell and tissue damage and organ dysfunction, leading to death (5) (6) (7) . Therefore it is critical to identify the cellular and immune pathways needed to mitigate the proinflammatory responses during sepsis.
Lipid-derived mediators (LMs) play key roles as signaling molecules to regulate acute inflammation (8) . LMs are enzymatically produced via specific cyclooxygenase (COX) and lipoxygenase (LOX) pathways (9) (10) (11) . During the onset of the resolution phase, eicosanoid class switching occurs through changes in production within the arachidonate-derived family, for example, in lipoxins (LXs) (12) . LXs generated by 15-lipoxygenase type I, specifically LXA 4 and LXB 4 , promote resolution of inflammation by reducing the entry of polymorphonuclear neutrophils (PMNs) to sites of inflammation and stimulating the clearance of apoptotic neutrophils by macrophages (13, 14) . This class of antiinflammatory and proresolving LMs is coined as specialized proresolving mediators (SPMs) (8) , and is essential for maintaining tissue homeostasis. Although the protective roles of SPMs are observed in several inflammatory disease models, the precise intracellular molecular mechanisms by which biosynthesis of SPMs are regulated in hosts or cells remains to be established.
In this study, we describe functional roles of the NLRP3 inflammasome in the regulation of LMs and proinflammatory cytokine production in a murine model of sepsis. We also demonstrate that caspase-7 is essential for NLRP3-dependent repression of LXB 4 synthesis, and that LXB 4 increased via genetic deletion of Nlrp3 or Casp7 may contribute to the amelioration of inflammation and mortality of sepsis. Some of the results of these studies have been previously reported in the form of abstracts (15, 16) .
Methods

Animals
Nlrp3
2/2 mice were obtained from Dr. Richard A. Flavell (Yale University, New Haven, CT) and were backcrossed 10 times against C57BL/6 (17) , and Il18 2/2 mice were purchased from Jackson Laboratory (Bar Harbor, ME) (19) (20) (21) .
Cecal Ligation and Puncture Model of Polymicrobial Sepsis
The cecal ligation and puncture (CLP) model of polymicrobial sepsis was performed with 10-to 12-week-old C57BL/6J wild-type male mice and Nlrp3 , and Il18 2/2 mice (17-21). The mouse cecum was ligated below the ileocecal valve. After ligation, the cecum was punctured once with a 23-gauge needle. Shamoperated mice underwent the same procedure, including opening of the peritoneum and exposing the bowel. No antibiotics were administered to the mice after surgery to assess the systemic inflammation based on polyintestinal bacteria (22, 23) . Preoperatively and postoperatively, all mice had unlimited access to food and water.
Therapeutic Administration of LXB 4
Some wild-type mice were injected with LXB 4 intravenously 10 minutes before CLP surgery. The dose was chosen based on previous studies showing the protective effects of other SPMs, such as RvD2 (24) and LXA 4 (25) (1 µg/mouse).
Sample Extraction and Lipid Mediator Metabololipidomics
All samples for liquid chromatographytandem mass spectrometry (LC-MS/MS) analysis were extracted using solid-phase extraction columns as described previously (26) . Identification was conducted using published criteria with at least six diagnostic ions (23) . Additional detail on the methods for metabololipidomics is provided in the online supplement. 
What This Study Adds to the
Field: This study suggests a critical role for the nucleotide-binding domain, leucine-rich repeatcontaining receptor, pyrin domaincontaining-3 inflammasome in regulating the biosynthesis of proresolving mediators, the latter of which may contribute to survival in murine polymicrobial sepsis.
we used two-tailed unpaired Student's t test or Mann-Whitney test. In experiments with more than two groups statistical differences were tested using a one-way analysis of variance followed by a Tukey test. The log-rank test was used to assess for differences in survival. P values of less than 0.05 were considered statistically significant.
Study Approval
All animals were housed in accordance with the guidelines from the American Association for Laboratory Animal Care. 
Results
NLRP3 Deficiency Promotes Resolution of Inflammation and Enhances Survival in an Experimental Sepsis Model
To investigate the role of the NLRP3 inflammasome in systemic acute inflammation in vivo, we first determined the effects of NLRP3 inflammasomeassociated molecules on the survival rate of mice subjected to CLP, a murine polymicrobial sepsis model. The NLRP3 deficient mice (Nlrp3 2/2 ) were more resistant to CLP-induced lethality than C57BL/6J wild-type mice ( Figure 1A) . Similarly, ASC deficient mice (Asc
2/2
) and P2rx7-deficient mice (P2rx7 2/2 ) were more resistant to CLP-induced lethality than wild-type mice (see Figures E1A and E1B in the online supplement). We also examined the role of IL-18, a representative inflammasome-mediated cytokine, on CLP-induced mortality. Interestingly, deficiency of IL-18 did not affect the mortality of mice after CLP (see Figure E2 ).
Next, we evaluated the effect of NLRP3 inflammasome on tissue injury and severity of animals with sepsis. Levels of circulating cell-free mtDNA, a mitochondrial DAMP associated with mortality and severity in patients with sepsis (27) (28) (29) , were increased 24 hours after CLP in wild-type mice ( Figure 1B) . The protein concentration of bronchoalveolar lavage fluid (BALF) and peritoneal lavage fluid, reflecting vascular permeability, were increased in wild-type mice after CLP ( Figure 1C ). In contrast, Nlrp3 2/2 mice displayed reduced levels of circulating mtDNA and protein concentration in both fluids, relative to wild-type mice ( Figures 1B and 1C) . We also observed that Nlrp3 deficiency significantly reduced the amount of live aerobic bacteria in blood at 24 hours after CLP, compared with wild-type mice subjected to CLP ( Figure 1D ). To examine the functional roles of NLRP3 on inflammatory responses in CLP-induced sepsis, we measured proinflammatory cytokines in plasma from Nlrp3 2/2 mice after CLP. We observed that the plasma levels of cytokines, such as IL-1b, tumor necrosis factor-a, and IL-6, were decreased in Nlrp3 2/2 mice, relative to wild-type mice ( Figure 1E ). Similarly the plasma levels of the antiinflammatory cytokine IL-10 were also decreased in Nlrp3 2/2 mice after CLP, relative to wildtype mice (see Figure E3) .
Infiltration of leukocytes into the inflammatory site is one of the important inflammatory events in the pathogenesis of sepsis. Macrophage inflammatory protein (MIP)-2, a potent chemoattractant, was increased in plasma ( Figure 1F ) and BALF (see Figure E4) , and the number of total leukocytes and PMNs was increased in the peritoneum of wild-type mice after CLP ( Figures 1G and 1H ). In contrast, Nlrp3 deficiency decreased the levels of MIP-2 in plasma and BALF of mice subjected to CLP, relative to wild-type mice (Figures 1F; see Figure E4 ). Consistent with the suppression of MIP-2 production, the recruitment of leukocytes including PMNs was also suppressed in Nlrp3 2/2 mice after CLP ( Figures 1G  and 1H ). These results indicate that deficiency of Nlrp3 reduced inflammatory responses and mortality in CLP-induced sepsis.
To examine the possibility that the protective phenotype observed in Nlrp3 2/2 mice after CLP may be related to changes in the virulence of colonic bacteria, we performed cecal slurry (CS) experiments. Similar to the CLP model, CS caused dose-dependent sepsis mortality when administered by intraperitoneal injection to wild-type mice (see Figure E5A ) (30) . CS derived from Nlrp3 2/2 mice caused comparable but significantly increased sepsis mortality relative to CS derived from wild-type mice when administered at a lethal dose (see Figure E5B ), suggesting that alterations in colonic flora do not directly contribute to the sepsis protection observed in Nlrp3 2/2 mice.
NLRP3 Deficiency Alters the Biosynthesis of Lipid Mediators
In Vivo and In Vitro
LMs play important roles as signaling molecules to regulate immune responses during early phase of acute inflammation (8) .
A recent study showed the involvement of NAIP5 (NLR family, apoptosis inhibitory protein 5)/NLRC4 inflammasome in LM biosynthesis (31) . To address the mechanisms by which Nlrp3 deficiency promoted resolution of inflammation in mice during CLP-induced sepsis, we performed mass spectrometry-based metabololipidomics focusing on local acting LM. We measured endogenous LMs in peritoneal lavage fluid from wild-type and Nlrp3 2/2 mice subjected to CLP. LMs were profiled using LC-MS-MS-based direct matching of their physical properties in LC-MS-MS with synthetic and authentic standards (Figures 2A and  2B ; see Table E1 ). We found that both COX and LOX pathways were regulated after CLP, with a time-dependent increase in prostaglandins and proresolving mediators ( Figure 2C ) including prostaglandins E 2 , LTB 4 , RvD1, RvD2, RvD5, and LXB 4 ( Figure 2D ) in wild-type mice during the early inflammatory phase (6-12 h after CLP). In Nlrp3 2/2 mice, proinflammatory LMs levels, such as LTB 4 , were lower than those in wild-type mice 12 hours after CLP ( Figures 2C and 2D ). In contrast, SPMs including LXA 4 , LXB 4 , and RvD5 were increased in peritoneal lavages from Nlrp3 2/2 mice at 6 hours after CLP, relative to wild-type mice ( Figure 2D ). Taken together, these results suggest that Nlrp3 deficiency enhanced survival from CLP-induced sepsis by up-regulating SPMs and down-regulating proinflammatory LMs. Of note, Nlrp3 deficiency up-regulated SPMs, such as LXB 4 , in mice subjected to CLP to levels that reached statistical significance, before proinflammatory LMs were downregulated ( Figure 2D ; see Table E1 ).
To assess the contribution of macrophages, critical cells in acute inflammation and inflammasome activation, to the biosynthesis of LMs, we investigated the LM profiles of bone marrow-derived macrophages (BMDMs) during NLRP3 inflammasome activation. We preincubated BMDMs with LPS and then stimulated with ATP. ATP-driven activation of caspase-1 in LPS-primed macrophages is an established model for NLRP3 inflammasome activation in vitro, which is mediated by P2rx7 and toll-like receptor 4 (32, 33) . We compared LM profiles between BMDMs from wild-type and Nlrp3 2/2 mice during NLRP3 inflammasome activation. LMs were profiled using LC-MS-MS-based direct or wild-type control (C57BL/6J) mice were subjected to CLP surgery. Rates of survival were determined for Nlrp3 2/2 mice after CLP (n = 10 per condition). Two independent experiments were performed (total n = 20 for each strain), and the representative survival curve is shown. *P , 0.0001 by log-rank test versus CLP wild-type mice. (B) Cell-free mitochondrial DNA in plasma from mice 24 hours after CLP and sham surgery was detected with cyclooxygenase I (COXI) primer via SYBR Green-based quantitative polymerase chain reaction. (C) Vascular permeability was validated by both bronchoalveolar lavage fluid and peritoneal lavage fluid protein concentration. (D) For determination of CFU, blood was serially diluted and then plated on LB plates. The LB plates were incubated for 24 hours at 37 8 C. The data represent the mean 6 SEM. *P , 0.01 by two-tailed MannWhitney U test. n = 15 for wild-type mice and n = 10 for Nlrp3 2/2 mice. (E) Plasma cytokine levels. IL-1b, tumor necrosis factor-a, and IL-6 were measured by ELISA in plasma from wild-type and Nlrp3 2/2 mice 24 hours after CLP, respectively. (F) Macrophage inflammatory protein-2 was measured by ELISA in plasma from wild-type and Nlrp3 2/2 mice after CLP. (G and H) Total peritoneal leukocyte number and the percentage of polymorphonuclear cells in peritoneal lavage fluid (B, C, and E-H). All data represent the mean 6 SEM (n = 3-8). *P , 0.05 by unpaired, two-tailed Student's t test (B, C, and E-H) versus sham wild-type mice; **P , 0.05 by unpaired, two-tailed Student's t test (B, C, and E-H) versus CLP wildtype mice. BALF = bronchoalveolar lavage fluid; MIP = macrophage inflammatory protein; NLRP3 = nucleotide-binding domain, leucine-rich repeatcontaining receptor, pyrin domain-containing-3; PMN = polymorphonuclear neutrophil; TNF = tumor necrosis factor. +H   141   375=M-H  357=M-H-H2O  339=M-H-2H2O  331=M-H-CO2  313=M-H-H2O-CO2  295=M-H-CO2-2H2O  215=233-H2O  197=233-2H2O  135=171- ORIGINAL ARTICLE matching of their physical properties in LC-MS-MS with synthetic and authentic standards (see Figure E6 ). We found that inflammasome activation by LPS and ATP up-regulated the COX and LOX biosynthetic pathways in wild-type and Nlrp3 2/2 macrophages ( Figure 3A ; see Table E2 ). Of note in these incubations we found marked and statistically significant increases in the levels of the proresolving mediator LXB 4 within 30 minutes of ATP treatment in LPS-primed Nlrp3
2/2
BMDMs when compared with wild-type BMDMs ( Figure 3B ). These findings are similar with those observed in peritoneal lavages from mice subjected to CLP (Figure 2) . ATP had no effect on LXB 4 biosynthesis in both wild-type and Nlrp3 2/2 cells by itself ( Figure 3B ). These results suggest that the NLRP3 inflammasome uniquely regulates the biosynthesis of the proresolving mediator LXB 4 in macrophages.
LXB 4 Enhances Survival in CLPinduced Sepsis
LXB 4 is biosynthesized in leukocytes from arachidonic acid generated through activation of cytosolic phospholipase A2 ( Figure 4A ). LXB 4 is particularly synthesized via two distinct lipoxygenation steps: first by lipoxygenation at the 15 position producing 15-hydroperoxyeicosatetraenoic acid that is then converted to LXB 4 by subsequent lipoxygenation and epoxidation steps ( Figure 4A ; see Figure E7 ) (34) . Although LXB 4 displays potent antiinflammatory properties as a SPM (35) , its precise roles in the pathogenesis of sepsis remain unclear. To examine the roles of LXB 4 in polymicrobial sepsis, mice were injected with LXB 4 intravenously and subjected to CLP. We observed that the number of total infiltrated leukocytes ( Figure 4B ) and PMNs that account for approximately 80% of the infiltrated leukocytes in peritoneum ( Figure 4C ) was decreased in LXB 4 -treated mice subjected to CLP, relative to vehicle-treated mice. Consequently, LXB 4 treatment enhanced the survival rate of the mice subjected to CLP ( Figure 4D ). These data suggest that LXB 4 may be a critical molecule to mediate the protective effect of Nlrp3 deficiency in CLP-induced sepsis.
NLRP3 Inflammasome-mediated Caspase-7 Activation Regulates LXB 4 
Production in Macrophages
We next assessed the mechanism by which NLRP3 regulated LXB 4 synthesis in vivo and in vitro. Recent studies suggest that caspase-7 is activated by the inflammasome (36) , and is involved in the susceptibility of mice to LPS-induced septic shock (37) . We first tested whether caspase-7 is regulated by NLRP3 inflammasome activation in macrophages. The cleaved form of caspase-7 was increased by LPS and ATP in wild-type macrophages ( Figure 5A ) (36) . However, the expression of cleaved caspase-7 did not increase in response to LPS and ATP in Nlrp3 2/2 BMDMs ( Figure 5A ), suggesting that the NLRP3 inflammasome regulates caspase-7 activation.
We next investigated the correlation of caspase-7 with caspase-1 activation using Casp7 deficient BMDMs. Deficiency of Casp7 did not affect basal levels of ASC and P2rx7 and LPS-induced NLRP3 expression. In addition, caspase-1 activation was comparable between Casp7 deficient cells and the wild-type cells in response to LPS and ATP ( Figure 5B ) (36) . Because the roles of caspase-7 on cell death remains unclear, we also examined the effect of caspase-7 on pyroptosis, a programmed cell death in immune cells during inflammation, by assessing lactate dehydrogenase (LDH) release. The secretion of LDH was increased in BMDMs during NLRP3 inflammasome activation ( Figure 5C ). Increased LDH secretion was suppressed in Nlrp3 2/2 , Asc 2/2 , and P2rx7 2/2 BMDMs, compared with wildtype cells in response to LPS and ATP ( Figure 5C ; see Figure E8 ). Casp7 deficiency also suppressed LDH secretion in macrophages during NLRP3 inflammasome activation ( Figure 5D ).
Because the LXB 4 biosynthesis and activation of caspase-7 were regulated by NLRP3 inflammasome activation ( Figures  3B and 5A) , we next assessed the role of caspase-7 on LXB 4 production during NLRP3 inflammasome activation. Importantly, we found an increase in the levels of the proresolving mediator LXB 4 in Casp7 2/2 BMDMs during NLRP3 inflammasome activation compared with wild-type BMDMs ( Figure 6A ). Furthermore, exogenous treatment of LXB 4 suppressed LDH secretion in BMDMs in response to LPS and ATP ( Figure 6B ), which may explain the antipyroptotic effect of caspase-7 deficiency. These findings are in accord with those observed in Nlrp3-deficient macrophages treated with LPS and ATP (Figure 3) . Thus, our results suggest that the increased generation of LXB 4 in Nlrp3 2/2 cells is mediated by suppression of caspase-7 activation. In addition, these data suggest that the NLRP3 inflammasome promotes pyroptosis by caspase-7-mediated inhibition of LXB 4 synthesis in macrophages.
Caspase-7 Deficiency Promotes Resolution of Inflammation and Enhances Survival in Sepsis
We also tested the in vivo relevance of caspase-7 in polymicrobial sepsis. Casp7 2/2 mice were more resistant to CLP-induced lethality than wild-type mice ( Figure 7A) . Furthermore, the protein concentrations of both BALF and peritoneal lavage fluid were decreased in Casp7 2/2 mice relative to wild-type mice after CLP (Figures 7B and  7C ). Plasma levels of proinflammatory cytokines, such as tumor necrosis factor-a and IL-6, were also decreased in Casp7 2/2 mice subjected to CLP, relative to wild-type mice ( Figure 7D ). We also observed that the levels of MIP-2 in BALF were also decreased in Casp7 2/2 mice after CLP (see Figure E9 ).
Because caspase-7 is involved in pyroptosis during NLRP3 inflammasome activation ( Figure 5D ) (36), we also assessed whether caspase-7 regulates macrophage cell death during CLP-induced sepsis. Cells in peritoneal fluid from Casp7 2/2 mice were stained with CD11b, a marker of leukocytes, and propidium iodide, a fluorescent membrane-impermeant molecule used for identifying dead cells. The number of CD11b-and propidium iodide-positive cells was increased in wildtype mice after CLP ( Figure 7E ), whereas there was no difference in the number of CD11b-and propidium iodide-positive cells between Casp7 2/2 mice subjected to either sham operation or CLP ( Figure 7E ). The number of CD11b-and propidium iodide-positive cells was also lower in Casp7 2/2 mice than wild-type mice after CLP ( Figure 7E) .
To address the mechanisms by which Casp7 deficiency rescued mice from CLPinduced sepsis, we analyzed the levels of 
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Lee, Nakahira, Dalli, et al.: NLRP3 Inflammasome in Proresolving Biosynthesislocal acting LM by performing mass spectrometry-based metabololipidomics. We measured endogenous LMs in peritoneal lavage fluid from wild-type and Casp7 2/2 mice subjected to CLP (Figures 8A and 8B ; see Table E3 ). Similar with those observed in Nlrp3 2/2 mice, proresolving mediator levels including LXB 4 were found to be significantly elevated in peritoneal lavages from Casp7 2/2 mice when compared with wild-type mice ( Figure 8B ). In addition, the levels of proinflammatory LMs including LTB 4 and TXB 2 were significantly reduced in these mice ( Figure 8B ). Taken together, similar to NLRP3, caspase-7 is also involved in inflammatory responses and the susceptibility of CLP-induced sepsis by regulating LM biosynthesis.
Critical Roles of LOX Activity in NLRP3 Deficiency during Sepsis
Finally, we examined whether increased production of endogenous LXB 4 in Nlrp3 2/2 mice contributed to the survival of sepsis by administrating baicalein, a potent LOX inhibitor (38) . We observed that baicalein treatment significantly increased the mortality of Nlrp3 2/2 mice after CLP, compared with Nlrp3 2/2 mice treated with vehicle ( Figure 9 ). This result suggests that the mechanism by which Nlrp3 deficiency rescued the mice from sepsis is mediated by increased synthesis of lipoxins.
Discussion
Physiologic resolution, namely the termination of acute inflammatory responses, is critical to maintain host homeostasis in response to infection (38) . This acute self-limiting response is characterized by active signaling molecules called SPMs that limit further inflammatory cell recruitment and enhance the phagocytosis of macrophages (39) . In this report, we demonstrate that NLRP3 inflammasomerelated molecules (e.g., NLRP3 and ASC) are critically involved in the pathogenesis of CLP-induced polymicrobial sepsis by augmenting acute inflammation and tissue injury. The mechanism by which Nlrp3 deficiency rescued septic mice was mediated by regulating the biosynthesis of LMs. We suggest that endogenous SPM (i.e., LXB 4 ) synthesis is regulated by NLRP3 inflammasomemediated caspase-7 activation and is a critical cytoprotective mechanism during CLP-induced sepsis, based on the following observations: LXB 4 synthesis is increased in leukocytes of Nlrp3-or Casp7-deficient mice at the earlier phase during sepsis. Second, deficiency of Nlrp3 or Casp7 reduced the susceptibility of mice to CLP-induced sepsis, accompanied by enhanced SPMs synthesis including LXB 4, but reduced proinflammatory mediators. LXB 4 treatment improved the survival of CLP-induced sepsis. Finally, pharmacologic inhibition of LOX, a critical enzyme for LXB 4 proinflammatory mediators, such as prostaglandin E 2 (31); however, the regulatory role of NLRP3 inflammasome in resolution of inflammation remains unclear. Our study demonstrates not only NLRP3 inflammasome-mediated LMs regulation, but also a unique role of NLRP3 in SPMs regulation and the resolution of inflammation through caspase-7 activation.
Increase of SPMs (e.g., LXB 4 ) observed at 6 hours after CLP was likely to be an early event to initiate the resolution of CLPinduced inflammation in Nlrp3 2/2 and Casp7 2/2 mice, because the levels of proinflammatory LMs, such as LTB 4 or TXB 2 , were significantly reduced at 12 hours after CLP in those mice. In addition, subsequent to the reduction of proinflammatory LMs, Nlrp3 2/2 and Casp7 2/2 mice displayed less vascular endothelial permeability, recruitment of proinflammatory cells and proinflammatory cytokine production at 24 hours after CLP. Furthermore, Nlrp3 2/2 mice also produced less antiinflammatory cytokine IL-10, suggesting the resolution of inflammation by NLRP3 deficiency was unlikely to be mediated by IL-10. The phenotype of Nlrp3 2/2 mice was not likely related to changes in the virulence of the colonic flora because CS from these mice caused slight increase in sepsis mortality relative to CS derived from control wild-type mice when administered to wildtype mice. All data represent the mean 6 SEM. *P , 0.05 by unpaired, two-tailed Student's t test versus wild-type control group; # P , 0.05 by unpaired, two-tailed Student's t test versus wild-type LPS and ATP treatment group. ASC = apoptosis-associated speck-like protein containing CARD; NLRP3 = nucleotide-binding domain, leucine-rich repeat-containing receptor, pyrin domain-containing-3; P2x7R = P2X7 receptor.
We also observed that SPM-mediated resolution of inflammation dampened the release of mitochondrial DAMPs (i.e., cellfree circulating mtDNA). Thus, early enhancement of SPMs before suppression of proinflammatory LMs in Nlrp3 2/2 mice suggests that Nlrp3 deficiency promotes the timely resolution of the inflammatory response by increased biosynthesis of SPMs during CLP-induced immune responses. Our study also describes a novel function of LXB 4 in inhibiting NLRP3 inflammasome-mediated pyroptosis. Although pyroptosis is often recognized as a beneficial host-defense response to prevent growth of intracellular microbes (3), excess macrophage cell death may contribute to the release of DAMPs, which further promote inflammatory responses and tissue (organ) injuries (40, 41) . We show that deficiency of Asc, Nlrp3, or P2rx7 improved the survival of mice subjected to CLPinduced sepsis and also inhibited pyroptosis in response to LPS and ATP, suggesting that inhibition of pyroptosis may be associated with improved survival from sepsis. Further studies are needed to identify the precise roles of pyroptosis in sepsis.
We found that several SPMs including LXA 4 and RvD5 were elevated in wild-type mice after CLP, whereas the levels of those SPMs were unchanged in wild-type BMDM-stimulated LPS and ATP. These differences observed between in vitro and in vivo experiments may reflect either differential biosynthetic origin for the mediators including different cell types or distinct routes of further metabolism. In addition, our data suggest that each SPM can be regulated by its distinctive signaling pathway. It is possible that Nlrp3 deficiency specifically activates 15-lipoxygenase, a critical enzyme for the biosynthesis of lipoxins ( Figure 4A ). Other possible mechanisms may include differential metabolic rates of LXB 4 between wild-type and Nlrp3-deficient macrophages. For example, it is possible that in Nlrp3-deficient cells, LXB 4 is less susceptible to further conversion by macrophage metabolic enzymes including 15-prostaglandin dehydrogenase (42) , which leads to the accumulation of LXB 4 in vitro and in vivo. The detailed mechanism by which NLRP3 regulates LXB 4 production remains to be established. Nonetheless, the present findings identify caspase-7, a downstream molecule of the NLRP3 inflammasome, as a key molecule for SPMs synthesis.
In conclusion, our results demonstrate that NLRP3-mediated LM regulation potentially contributed to inflammation and susceptibility of CLPinduced sepsis. Moreover, the NLRP3 inflammasome regulates LM synthesis by activating caspase-7. Although it remains unclear how LXB 4 -mediated antipyroptosis regulates inflammation and susceptibility to sepsis, our present results provide a novel molecular link between NLRP3, caspase-7, and endogenous LM biosynthesis. The NLRP3 inflammasome has well-known pleiotropic and potentially "double-edged sword" effects in infection as a regulator of inflammation and an integral part of the immune response. Excessive inflammasome-mediated immune responses can also potentially exacerbate tissue injury (1, 2) . In this regard, our study demonstrates the beneficial roles of Nlrp3 deficiency (i.e., inhibiting inflammation, tissue injuries, and death) in polymicrobial septic mice.
Our study has several important limitations. First, the injection of LXB 4 at a pharmacologic dose, which provided significant protection in sepsis, likely exceeded that of the measured endogenous production of this mediator, and thus does not necessarily establish the efficacy, nor recapitulate the physiologic context of naturally occurring LXB 4 . Second, the pan-LOX inhibitor baicalein, which protected Nlrp3 2/2 mice against CLP, is not entirely specific for 12/15 LOX, and may also affect Ca 21 flux. The application of baicalein in the wild-type mice displayed a trend toward sepsis protection that did not reach statistical significance. Finally, the Nlrp3 2/2 mice displayed partial reduction of IL-1b in the plasma in response to CLP. Previous studies have described resistance phenotypes in IL-1b/IL-18 double knockout mice subjected to CLP (43) . We have also observed in our studies a resistance phenotype of Il1r 2/2 mice (data not shown). However, Il18 2/2 mice had no phenotype as shown in Figure E2 . Therefore, although our data support a protective role for LXB 4 , it remains possible that differences in production of IL-1b and other cytokines may contribute to the prosurvival phenotype of Nlrp3 2/2 mice during sepsis development.
Although translation of the current findings to the human condition remains speculative, individuals with genetic predisposition to enhanced NLRP3 inflammasome responses may conceivably be at increased risk for sepsis-induced mortality. Our recent studies suggest that LM profiles were altered in critically ill patients with sepsis. We found increases in proinflammatory mediators (e.g., prostaglandin F 2a and leukotriene B4) and proresolving mediators (e.g., resolvin E1, resolvin D5, and 17R-protectin D1), in sepsis nonsurvivors relative to nonsurvivors, and that altered mediator profiles were predictive of respiratory failure (44) . Although our current studies suggest that LXB 4 is an important proresolving mediator in responses to sepsis in the mouse, further research is needed to evaluate the potential of LXB 4 and other SPMs as useful biomarkers of the progression of human sepsis. Given several reports showing critical roles of NLRP3 in inflammation, this unique regulation of SPMs biosynthesis by NLRP3 and caspase-7 may provide new therapeutic strategies for the excess morbidity and mortality associated with this disease and related inflammatory disorders. n 
